Related Experiment Videos
QTc interval in the assessment of cardiac risk
Hanne Elming1, Bente Brendorp, Lars Køber
1Department of Cardiology, Rigshospitalet Heart Center, Copenhagen, Denmark. he@heart.dk
Insights
Prolonged QTc intervals can predict sudden cardiac death risk and guide treatment decisions. Monitoring QTc is crucial for managing patients with heart conditions and those on QTc-prolonging medications.
Area of Science:
- Cardiology
- Electrophysiology
- Clinical Risk Assessment
Background:
- Sudden cardiac death (SCD) is a significant cause of mortality, often linked to ventricular tachyarrhythmias.
- Prolonged QTc, indicating cardiac repolarization abnormalities, is associated with increased arrhythmia risk.
Purpose of the Study:
- To review the utility of QTc interval measurements in assessing the risk of ventricular arrhythmia and cardiac death.
- To evaluate the prognostic significance of QTc in various cardiovascular diseases and during drug therapy.
Main Methods:
- Review of existing literature and clinical data on QTc interval.
- Analysis of prognostic value of QTc in different patient populations and conditions.
- Evaluation of QTc prolongation thresholds for drug initiation and withdrawal.
Main Results:
- Prolonged QTc is an independent predictor of mortality in ischemic heart disease and diabetes mellitus.
- The prognostic role of QTc is less certain in heart failure and hypertension.
- In congenital long QT syndrome, QTc magnitude aids diagnosis and prognosis.
- QTc has limited prognostic value in hypertrophic cardiomyopathy and arrhythmogenic right ventricular disease.
- Degree of QTc prolongation during drug therapy predicts torsade de pointes risk.
Conclusions:
- Specific QTc thresholds (e.g., >460 ms for initiation, >500 ms for withdrawal) are recommended for QTc-prolonging drugs.
- QTc monitoring can identify heart failure patients who may benefit from antiarrhythmic therapy.
- QTc interval is a valuable tool for risk stratification and guiding therapeutic interventions in various cardiac conditions.
Abstract:
In the United States alone 300,000-400,000 people die of sudden cardiac death every year. Much of this mortality is assumed to be caused by ventricular tachyarrhythmias. Prolonged QTc reflect cardiac repolarization prolongation and/or increased repolarization inhomogenity known to be associated with increased risk of arrhythmias. The paper gives a review of the possibilities to assess the risk of ventricular arrhythmia and/or cardiac death from QTc. Prolonged QTc may hold independent prognostic importance for mortality in common diseases as ischemic heart disease and diabetes mellitus where as the prognostic importance in heart failure and arterial hypertension is more uncertain. In more rare diseases as the inborn long QT syndrome the QT interval gives not only important hint to the diagnosis but the magnitude also provides information on prognosis. QTc has probably no independent prognostic importance in hypertrophic cardiomyopathy or in the arrhythmogenic right ventricular disease. The degree of QTc prolonging during treatment with QTc prolonging drugs is prognostic for the risk of ventricular arrhythmia in form of torsade de pointes and QTc prolonging drugs should probably not be prescribed for patients with a QTc greater than 460 ms and withdrawn if QTc exceeds 500 ms during treatment. Data from the DIAMOND study suggest that QTc can be used to point out those heart failure patients who will benefit from antiarrhythmic therapy.